Покровский Вадим Валентинович


Сортировать:

RAL/ABC/3TC - HIV/TB ClinicalTrials.gov

Статус: Completed
Фаза: Phase 4
Начало: 1 октября 2010 г.
Окончание: 1 мая 2013 г.
Описание: The study will investigate whether combination antiretroviral therapy of raltegravir and 3TC/ABC is effective and safe to use in tuberculosis (TB)/HIV co-infected adults receiving rifabutin-containing, first-line antituberculous treatment. Hypothesis:Combination antiretroviral therapy of raltegravir and 3TC/ABC and is effective and safe to use in tuberculosis (TB)/HIV co-infected adults receiving rifabutin-based first-line antituberculous treatment.
смотреть на ClinicalTrials.gov